CN Patent

CN112823020A — 用于治疗干眼病的眼用组合物

Assigned to Novaliq GmbH · Expires 2021-05-18 · 5y expired

What this patent protects

本发明提供了包含溶解于1‑(全氟丁基)戊烷中的约0.1％(w/v)环孢菌素的眼用组合物，其用于局部治疗干眼病。本发明进一步提供了用于相同用途的包含此类组合物的试剂盒。

USPTO Abstract

本发明提供了包含溶解于1‑(全氟丁基)戊烷中的约0.1％(w/v)环孢菌素的眼用组合物，其用于局部治疗干眼病。本发明进一步提供了用于相同用途的包含此类组合物的试剂盒。

Drugs covered by this patent

Patent Metadata

Patent number
CN112823020A
Jurisdiction
CN
Classification
—
Expires
2021-05-18
Drug substance claim
No
Drug product claim
No
Assignee
Novaliq GmbH
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.